Potential risk of blood transfusion‐transmitted brucellosis in an endemic area of China

By  

TRANSFUSION, Vol. 55, Iss. 3, 2015-03 ,pp. : 586-592

John Wiley & Sons Inc

Access to resources Recommend Favorite

Integrative Medicine and Drug-Induced Vestibulopathy following Brucellosis Treatment: Clinical Practice

By  

Integrative Medicine International, Vol. 1, Iss. 3, 2015-02 ,pp. : 176-184

Karger

Access to resources Recommend Favorite

APOC's strategy of community-directed treatment with ivermectin (CDTI) and its potential for providing additional health services to the poorest populations

By Homeida M.   Braide E.   Elhassan E.   Amazigo U. V.   Liese B.   Benton B.   Noma M.   Etya'Alé D.   Dadzie K. Y.   Kale O. O.   Sékétéli A.  

Annals of Tropical Medicine and Parasitology, Vol. 96, Iss. 1, 2002-03 ,pp. : 93-104

Maney Publishing

Access to resources Recommend Favorite

An update on serum amyloid A-LDL and its potential use for dyslipidemic patients receiving lipid-modulating treatment

By Kotani Kazuhiko  

Clinical Lipidology, Vol. 8, Iss. 4, 2013-08 ,pp. : 419-423

Future Medicine

Access to resources Recommend Favorite

Susceptibility of Mexican Brucella Isolates to Moxifloxacin, Ciprofloxacin and other Antimicrobials Used in the Treatment of Human Brucellosis

By López-merino Ahidé   Contreras-rodríguez Araceli   Migranas-ortiz Roberto   Orrantia-gradín Rubén   Hernández-oliva Gerardo M.   Torres Y Gutiérrez-rubio Arturo   Cardeñosa Oscar  

Scandinavian Journal of Infectious Diseases, Vol. 36, Iss. 9, 2004-09 ,pp. : 636-638

Informa Healthcare

Access to resources Recommend Favorite